MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CARM made $45,250K in revenue. $44,717K in net income. Net profit margin of 98.82%.

Income Overview

Revenue
$45,250K
Net Income
$44,717K
Net Profit Margin
98.82%
EPS
$1.07
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenues
45,250 0 3,729 759*
Research and development
197 2,424 9,156 19,724*
General and administrative
1,239 3,354 3,907 5,994*
Total operating expenses
1,436 5,778 13,063 25,717*
Operating loss
43,814 -5,778 -9,334 -24,958*
Gain (loss) on sale of held for sale assets
320 -3,539 --
Loss on abandonment of operating lease right-of-use asset
0 927 --
Interest income, net
--68 277*
Other income, net
583 470 --
Pre-tax income(loss)
44,717 -9,774 -9,266 -
Income tax expense
0 0 --
Net income(loss)
44,717 -9,774 -9,266 -24,681
Comprehensive loss
----24,681
Basic EPS
1.07 -0.23 -0.22 -0.595
Diluted EPS
1.07 -0.23 -0.22 -0.595
Basic Average Shares
41,788,096 41,788,096 41,771,213 41,456,210*
Diluted Average Shares
41,940,292 41,788,096 41,771,213 41,456,210*
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Collaboration revenues$45,250K (1236.78%↑ Y/Y)Operating loss$43,814K (433.34%↑ Y/Y)Other income, net$583K Gain (loss) on sale ofheld for sale assets$320K Total operatingexpenses$1,436K (-91.31%↓ Y/Y)Pre-tax income(loss)$44,717K (452.05%↑ Y/Y)General andadministrative$1,239K (-76.19%↓ Y/Y)Research and development$197K (-98.26%↓ Y/Y)Net income(loss)$44,717K (452.05%↑ Y/Y)

Carisma Therapeutics Inc. (CARM)

Carisma Therapeutics Inc. (CARM)